113
FRONTKEN CORPORATION BERHAD
(651020-T)
ANNUAL REPORT
2015
26.
FINANCIAL INSTRUMENTS (CONT’D)
(a) Financial Risk Management Policies (Cont’d)
(iii) Equity price risk
The Group does not have any quoted investment that is exposed to equity price risk.
(iv) Credit risk
The Group’s exposure to credit risk, or the risk of counterparties defaulting, arises mainly from receivables. The
Group manages its exposure to credit risk by the application of credit approvals, credit limits and monitoring
procedures on an ongoing basis.
The Group establishes an allowance for impairment that represents its estimate of incurred losses in respect
of the trade and other receivables as appropriate. The main components of this allowance are a specific loss
component that relates to individually significant exposures, and a collective loss component established for
groups of similar assets in respect of losses that have been incurred but not yet identified (where applicable).
Impairment is estimated by management based on prior experience and the current economic environment.
The Company provides financial guarantee to financial institutions for credit facilities granted to certain
subsidiaries. The Company monitors the results of these subsidiaries regularly and repayments made by the
subsidiaries.
Credit risk concentration profile
The Group does not have any major concentration of credit risk related to any individual customer or
counterparty.
Exposure to credit risk
At the end of the reporting period, the maximum exposure to credit risk is represented by the carrying amount
of each class of financial assets recognised in the statement of financial position of the Group and of the
Company after deducting any allowance for impairment losses (where applicable).
Ageing analysis
The ageing of the Group’s trade receivables as at end of the reporting period was:-
Gross
Individual
Collective
Carrying
Amount
Impairment
Impairment
Value
The Group
RM
RM
RM
RM
2015
Not past due
73,326,282
-
-
73,326,282
Past due:-
- Less than 1 month
6,673,097
-
-
6,673,097
- 1 to 9 months
7,334,292
-
(357,750)
6,976,542
- over 9 months
1,585,605
(1,248,002)
(283,905)
53,698
88,919,276
(1,248,002)
(641,655)
87,029,619
NOTES TO THE FINANCIAL STATEMENTS
(cont’d)